Hoenle AG (ETR:HNL)
Germany · Delayed Price · Currency is EUR 8.52
+0.04 (0.47%)
Jul 3, 2026, 5:35 PM CET
Hoenle AG Earnings Call Transcripts
Fiscal Year 2026
-
Revenue and EBITDA improved sequentially, with Adhesive and Disinfection units showing growth, while Curing faced continued challenges from weak investment and customer insolvency. Full-year guidance is maintained, but expectations are toward the lower end due to market uncertainty.
-
Q1 sales and EBITDA were flat to slightly down year-over-year, with Disinfection showing strong growth while Curing lagged due to weak investment demand. Full-year guidance is maintained, with expectations for stronger performance in the second half and ongoing cost control.